The global dialysis concentrates and solutions market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of chronic kidney disease, rising awareness about the benefits of dialysis therapy, and technological advancements in the field.
Acid concentrates are expected to be the fastest-growing segment in this market during the forecast period due to their high demand for use in home dialysis therapy. Bicarbonate concentrates are also expected to grow at a significant rate due to their use as an alternative for acid concentrate when there is an increased risk of acidosis or metabolic alkalosis.
- Increasing awareness about the benefits of hemodialysis over peritoneal dialysis is also driving the growth in this market.
- In addition, increasing number of patients with end-stage renal disease (ESRD) will drive the demand for these products in this market during the forecast period from 2017 to 2022 5.The high cost associated with these products will be a restraining factor for this market during the forecast period from 2017 to 2022.
Industry Growth Insights published a new data on “Dialysis Concentrates and Solutions Market”. The research report is titled “Dialysis Concentrates and Solutions Market research by Types (Acid Concentrates, Bicarbonate Concentrates, Modifiers For Haemodialysis Concentrates), By Applications (Dialysis Center, Home Dialysis, Other), By Players/Companies Fresenius, Baxter, B. Braun, Haemo Pharma, Nipro, Unipharm JSC, Rockwell Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dialysis Concentrates and Solutions Market Research Report
By Type
Acid Concentrates, Bicarbonate Concentrates, Modifiers For Haemodialysis Concentrates
By Application
Dialysis Center, Home Dialysis, Other
By Companies
Fresenius, Baxter, B. Braun, Haemo Pharma, Nipro, Unipharm JSC, Rockwell Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Dialysis Concentrates and Solutions Market Report Segments:
The global Dialysis Concentrates and Solutions market is segmented on the basis of:
Types
Acid Concentrates, Bicarbonate Concentrates, Modifiers For Haemodialysis Concentrates
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dialysis Center, Home Dialysis, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius
- Baxter
- B. Braun
- Haemo Pharma
- Nipro
- Unipharm JSC
- Rockwell Medical
Highlights of The Dialysis Concentrates and Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acid Concentrates
- Bicarbonate Concentrates
- Modifiers For Haemodialysis Concentrates
- By Application:
- Dialysis Center
- Home Dialysis
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dialysis Concentrates and Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dialysis concentrates and solutions are a type of medical treatment that help to remove waste and toxins from the blood. Dialysis is a process that uses machines to clean the blood.
Some of the key players operating in the dialysis concentrates and solutions market are Fresenius, Baxter, B. Braun, Haemo Pharma, Nipro, Unipharm JSC, Rockwell Medical.
The dialysis concentrates and solutions market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Dialysis Concentrates and Solutions Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Dialysis Concentrates and Solutions Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Dialysis Concentrates and Solutions Market - Supply Chain
4.5. Global Dialysis Concentrates and Solutions Market Forecast
4.5.1. Dialysis Concentrates and Solutions Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Dialysis Concentrates and Solutions Market Size (000 Units) and Y-o-Y Growth
4.5.3. Dialysis Concentrates and Solutions Market Absolute $ Opportunity
5. Global Dialysis Concentrates and Solutions Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Dialysis Concentrates and Solutions Market Size and Volume Forecast by Type
5.3.1. Acid Concentrates
5.3.2. Bicarbonate Concentrates
5.3.3. Modifiers For Haemodialysis Concentrates
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Dialysis Concentrates and Solutions Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Dialysis Concentrates and Solutions Market Size and Volume Forecast by Application
6.3.1. Dialysis Center
6.3.2. Home Dialysis
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Dialysis Concentrates and Solutions Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Dialysis Concentrates and Solutions Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Dialysis Concentrates and Solutions Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Dialysis Concentrates and Solutions Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Dialysis Concentrates and Solutions Demand Share Forecast, 2019-2026
9. North America Dialysis Concentrates and Solutions Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Dialysis Concentrates and Solutions Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Dialysis Concentrates and Solutions Market Size and Volume Forecast by Application
9.4.1. Dialysis Center
9.4.2. Home Dialysis
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Dialysis Concentrates and Solutions Market Size and Volume Forecast by Type
9.7.1. Acid Concentrates
9.7.2. Bicarbonate Concentrates
9.7.3. Modifiers For Haemodialysis Concentrates
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Dialysis Concentrates and Solutions Demand Share Forecast, 2019-2026
10. Latin America Dialysis Concentrates and Solutions Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Dialysis Concentrates and Solutions Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Dialysis Concentrates and Solutions Market Size and Volume Forecast by Application
10.4.1. Dialysis Center
10.4.2. Home Dialysis
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Dialysis Concentrates and Solutions Market Size and Volume Forecast by Type
10.7.1. Acid Concentrates
10.7.2. Bicarbonate Concentrates
10.7.3. Modifiers For Haemodialysis Concentrates
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Dialysis Concentrates and Solutions Demand Share Forecast, 2019-2026
11. Europe Dialysis Concentrates and Solutions Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Dialysis Concentrates and Solutions Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Dialysis Concentrates and Solutions Market Size and Volume Forecast by Application
11.4.1. Dialysis Center
11.4.2. Home Dialysis
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Dialysis Concentrates and Solutions Market Size and Volume Forecast by Type
11.7.1. Acid Concentrates
11.7.2. Bicarbonate Concentrates
11.7.3. Modifiers For Haemodialysis Concentrates
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Dialysis Concentrates and Solutions Demand Share, 2019-2026
12. Asia Pacific Dialysis Concentrates and Solutions Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Dialysis Concentrates and Solutions Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Dialysis Concentrates and Solutions Market Size and Volume Forecast by Application
12.4.1. Dialysis Center
12.4.2. Home Dialysis
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Dialysis Concentrates and Solutions Market Size and Volume Forecast by Type
12.7.1. Acid Concentrates
12.7.2. Bicarbonate Concentrates
12.7.3. Modifiers For Haemodialysis Concentrates
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Dialysis Concentrates and Solutions Demand Share, 2019-2026
13. Middle East & Africa Dialysis Concentrates and Solutions Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Dialysis Concentrates and Solutions Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Dialysis Concentrates and Solutions Market Size and Volume Forecast by Application
13.4.1. Dialysis Center
13.4.2. Home Dialysis
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Dialysis Concentrates and Solutions Market Size and Volume Forecast by Type
13.7.1. Acid Concentrates
13.7.2. Bicarbonate Concentrates
13.7.3. Modifiers For Haemodialysis Concentrates
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Dialysis Concentrates and Solutions Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Dialysis Concentrates and Solutions Market: Market Share Analysis
14.2. Dialysis Concentrates and Solutions Distributors and Customers
14.3. Dialysis Concentrates and Solutions Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fresenius
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Haemo Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nipro
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Unipharm JSC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Rockwell Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
